It's all Rel-ative: NF-κB and CD28 costimulation of T-cell activation

Trends in Immunology

Volumn 23, Issue 8, 2002, Pages 413-420

  Kane, Lawrence P ^a   Lin, Joseph ^a   Weiss, Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR;

CELL STIMULATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; KNOCKOUT MOUSE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD28; HUMANS; ISOENZYMES; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE KINASE 1; MAP KINASE KINASE KINASE 2; MAP KINASE KINASE KINASES; NF-KAPPA B; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0036679733     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(02)02264-0     Document Type: Review

References (81)

1. Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice
2. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation
3. The CD28-B7 costimulatory pathway and its role in autoimmune disease
4. Activation and inhibition of lymphocytes by costimulation
5. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance
6. Distinct roles for LFA-1 and CD28 during activation of naïve T cells: Adhesion versus costimulation
7. The B7-CD28 superfamily
8. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines
9. Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells
10. T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways
11. NF-κB signaling pathways in mammalian and insect innate immunity
12. Missing pieces in the NF-κB puzzle
13. Kappa B-specific DNA binding proteins: Role in the regulation of human interleukin-2 gene expression
14. Activation of the interleukin-2 receptor alpha gene: Regulatory role for DNA-protein interactions flanking the kappa B enhancer
15. A second sequence element located 3′ to the NF-κB-binding site regulates IL-2 receptor-alpha gene induction
16. Physiologic activation of T cells via the T cell receptor induces NF-κB
17. NF-κB subunit regulation in nontransformed CD4+ T lymphocytes
18. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28
19. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28
20. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element
21. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation
22. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites
23. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter
24. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters
25. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-κB/Rel transcription factors
26. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 element/AP-1 sequence in human T cells
27. The interleukin 2 CD28-responsive complex contains at least three members of the NF-κB family: C-Rel, p50, and p65
28. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
29. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation
30. Functional disparity of distinct CD28 response elements toward mitogenic responses
31. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL
32. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L)
33. The NF-κB cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes
34. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: Requirement for CD28 up-regulation of RE/AP
35. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation
36. NF-κB: A family of inducible and differentially expressed enhancer-binding proteins in human T cells
37. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells
38. Temporal and subunit-specific modulations of the Rel/NF-κB transcription factors through CD28 costimulation
39. Differential regulation of c-Rel translocation in activated B and T cells
40. C-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation
41. CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers
42. CD28 signaling causes a sustained down-regulation of IκBα which can be prevented by the immunosuppressant rapamycin
43. I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity
44. Genetic approaches in mice to understand Rel/NF-κB and IκB function: Transgenics and knockouts
45. IκB kinases serve as a target of CD28 signaling
46. Primary human CD4+ T cells contain heterogeneous IκB kinase complexes: Role in activation of the IL-2 promoter
47. Mitogen-activated kinase kinase kinase 1 regulates T cell receptor-and CD28-mediated signaling events which lead to NF-κB activation
48. Somatic mutagenesis studies of NF-κB signaling in human T cells: Evidence for an essential role of IKK γ in NF-κB activation by T-cell costimulatory signals and HTLV-I Tax protein
49. A new family of IKK-related kinases may function as IκB kinase kinases
50. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases
51. Signal transduction by the TCR for antigen
52. Lymphocytes with a complex: Adapter proteins in antigen receptor signaling
53. ZAP-70 and SLP-76 regulate protein kinase C-? and NF-κB activation in response to engagement of CD3 and CD28
54. Vav proteins, adaptors and cell signaling
55. A novel functional interaction between Vav and PKC? is required for TCR-induced T cell activation
56. Vav1 transduces T cell receptor signals to the activation of phospholipase Cγ1 via phosphoinositide 3-kinase-dependent and -independent pathways
57. Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IκB kinase complex
58. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases
59. The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines
60. The tao of MEKK
61. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway
62. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase
63. Induction of NF-κB by the Akt/PKB kinase
64. Akt provides the CD28 co-stimulatory signal for upregulation of IL-2 and IFN-γ but not Th2 cytokines
65. Complex formation and cooperation of protein kinase C θ and Akt1/protein kinase Bα in the NF-κB transactivation cascade in Jurkat T cells
66. NF-κB activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-?
67. Protein kinase C-θ participates in NF-κB activation induced by CD3-CD28 costimulation through selective activation of IκB kinase β
68. Akt-dependent phosphorylation specifically regulates Cot induction of NF-κB-dependent transcription
69. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
70. Protein kinase C?: A new essential superstar on the T-cell stage
71. Bcl10
72. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure
73. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-κB induction
74. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κB signaling pathway
75. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems
76. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family
77. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-κB activation
78. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κB
79. The physical association of protein kinase C ? with a lipid raft-associated inhibitor of κ B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28
80. T cell co-stimulatory molecules other than CD28
81. T-lymphocyte coactivator molecules